← Latest news 
Emcure Pharma block deal Rs 289 crore ends as Norges Bank buys 18 lakh shares
Business
Published on 29 April 2026
Norges Bank quietly steps in after shares jump
Emcure Pharmaceuticals reported a major block deal as BC Investments IV Limited sold about 18 lakh shares worth Rs 289 crore to Norges Bank. The buyer’s entry comes as the pharma company keeps outperforming, posting a 67% return over the past 12 months and a 50% year-on-year jump in net profit, bolstering investor interest.
- BC Investments IV sold roughly 18 lakh Emcure shares for Rs 289 crore
- Norges Bank is the reported buyer in the block deal
- Emcure delivered strong momentum with 67% returns in 12 months
- Net profit rose 50% year-on-year, lifting investor optimism
Read the full story at The Economic Times
This summarization was done by Beige for a story published on 
The Economic Times